Ticker Details
Zai Lab Limited Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.34B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.16 | 2.43%
Avg Daily Range (30 D):	$0.31 | 1.67%
Avg Daily Range (90 D):	$0.27 | 1.44%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	3,439
Avg Institutional Trade:	$2.51M
Avg Institutional Trade (30 D):	$1.46M
Avg Institutional Trade (90 D):	$1.49M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.6M
Avg Closing Trade (30 D):	$1.48M
Avg Closing Trade (90 D):	$1.33M
Avg Closing Volume:	51.29K

News

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Sep 11, 2025 @ 12:02 PM Zai Lab's Double Whammy: Earnings Miss, Phase 3 Se... Source: Bamboo Works Benzinga Contributor

Jul 16, 2025 @ 10:51 PM Cancer Pipeline Milestones Coming Fast as Regulato... Source: Prnewswire

Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight

Jul 16, 2024 @ 4:32 AM argenx and Zai Lab Announce Approval of Efgartigim... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.16	$-.05	$-.16
Diluted EPS	$-.16	$-.05	$-.16
Revenue	$460.16M	$127.6M	$460.16M
Gross Profit	$269.64M	$65.3M	$269.64M
Net Income / Loss	$-175.54M	$-50.41M	$-175.54M
Operating Income / Loss	$-229.43M	$-69.41M	$-229.43M
Cost of Revenue	$190.52M	$62.3M	$190.52M
Net Cash Flow	$229.43M	$-37.75M	$229.43M
PE Ratio